Prevalence of chronic obstructive pulmonary disease among stable chronic disease subjects in primary care in trinidad, West Indies

Journal of Thoracic Disease

Volumn 3, Issue 3, 2011, Pages 177-182

  Thorington, Peterson ^a   Rios, Maria ^a   Avila, Gina ^a   Henry, Josia ^a   Haynes, C ^a   Pinto Pereira, Lexley M ^a   Seemungal, Terence A R ^a  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855519671     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2011.03.03     Document Type: Article

References (22)

1. Calverley PM, Walker P. Chronic obstructive pulmonary disease. Lancet 2003;362:1053-61.
2. Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar MC, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med 1997;127:1072-9.
3. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
4. Buist AS, Vollmer WM, Sullivan SD, Weiss KB, Lee TA, Menezes AM, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD 2005;2:277-83.
5. Seemungal T, Harrinarine R, Rios M, Abiraj V, Ali A, Lacki N, et al. Obstructive lung disease in acute medical patients. West Indian Med J 2008;57:7-13.
6. Seemungal TA, Lun JC, Davis G, Neblett C, Chinyepi N, Dookhan C, et al. Plasma homocysteine is elevated in COPD patients and is related to COPD severity. Int J Chron Obstruct Pulmon Dis 2007;2:313-21.
7. American Association for Respiratory Care. AARC clinical practice guideline to spirometry, 1996 update. Respir Care 1996;41:629-36.
8. MRC Committee on Aetiology of Chronic Bronchitis. Standardised questionnaires on respiratory symptoms. BMJ 1960;2:1665.
9. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38.
10. Chapman KR. Chronic obstructive pulmonary disease: are women more susceptible than men? Clin Chest Med 2004;25:331-41.
11. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. MMWR Surveill Summ 2002;51:1-16.
12. Tanoue LT. Cigarette smoking and women's respiratory health. Clin Chest Med 2000;21:47-65.
13. Soriano JB, Maier WC, Egger P, Visick G, Thakrar B, Sykes J, et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000;55:789-94.
14. Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest 2001;119:1691-5.
15. Ran PX, Wang C, Yao WZ, Chen P, Kang J, Huang SG, et al. The risk factors for chronic obstructive pulmonary disease in females in Chinese rural areas. Zhonghua Nei Ke Za Zhi 2006;45:974-9. Chinese.
16. Matheson MC, Benke G, Raven J, Sim MR, Kromhout H, Vermeulen R, et al. Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease. Thorax 2005;60:645-51.
17. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50.
18. Van Schayck CP, Loozen JM, Wagena E, Akkermans RP, Wesseling GJ. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ 2002;324:1370.
19. Khan A, Shabbir K, Ansari JK, Zia N. Comparison of forced expiratory volume in one second (FEV1) among asymptomatic smokers and nonsmokers. J Pak Med Assoc 2010;60:209-13.
20. Schünemann HJ, Dorn J, Grant BJ, Winkelstein W Jr, Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000;118:656-64.
21. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107:1514-9.
22. Friedman GD, Klatsky AL, Siegelaub AB. Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med 1976;294:1071-5.S